Multimorbidity in Randomized Controlled Trials of Behavioral Interventions: A Systematic Review.

Objective: As the population with multiple chronic conditions (MCC) increases, it is essential that randomized controlled trials (RCTs) consider MCC. Behavioral interventions have the potential to positively impact MCC patient outcomes; however, a comprehensive review of consideration of MCC in thes...

Descripción completa

Detalles Bibliográficos
Publicado en:Health Psychology Vol. 38; no. 9; pp. 831 - 840
Autores principales: Stoll, Carolyn R. T., Izadi, Sonya, Fowler, Susan, Philpott-Streiff, Sydney, Green, Paige, Suls, Jerry, Winter, Anke C., Colditz, Graham A.
Formato: Artículo
Publicado: American Psychological Association Sep2019
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=138245247&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 138245247
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        02786133
        82X
      jtl: Health Psychology
      issn: 02786133
      maglogo: N
    pubinfo:
      dt: Sep2019
      vid: 38
      iid: 9
      pid: 34
      pub: American Psychological Association
    artinfo:
      ui:
        138245247
        10.1037/hea0000726
      ppf: 831
      ppct: 9
      formats:
      tig:
        atl: Multimorbidity in Randomized Controlled Trials of Behavioral Interventions: A Systematic Review.
      aug:
        au:
          Stoll, Carolyn R. T.
          Izadi, Sonya
          Fowler, Susan
          Philpott-Streiff, Sydney
          Green, Paige
          Suls, Jerry
          Winter, Anke C.
          Colditz, Graham A.
        affil:
          Washington University School of Medicine
          National Cancer Institute. Bethesda. Maryland
      su:
        Behavior therapy
        Interprofessional relations
        Chronic disease treatment
        Medical information storage & retrieval systems
        MEDLINE
        Risk assessment
        Statistical sampling
        Systematic reviews
        Comorbidity
      sug:
        subj:
          Behavior therapy
          Interprofessional relations
          Marketing Research and Public Opinion Polling
          Chronic disease treatment
          Medical information storage & retrieval systems
          MEDLINE
          Risk assessment
          Statistical sampling
          Systematic reviews
          Comorbidity
      keyword:
        behavioral medicine
        multimorbidity
        randomized clinical trials
        systematic review
        behavioral medicine
        multimorbidity
        randomized clinical trials
        systematic review
      ab: Objective: As the population with multiple chronic conditions (MCC) increases, it is essential that randomized controlled trials (RCTs) consider MCC. Behavioral interventions have the potential to positively impact MCC patient outcomes; however, a comprehensive review of consideration of MCC in these trials has not been conducted. The purpose of this systematic review is to determine the frequency with which participants with MCC are represented in behavioral intervention RCTs targeting chronic illness published 2000-2014. Method: MEDLINE and EMBASE were searched from 2000 to 2014 to identify RCTs testing behavioral interventions among adults with chronic illness. A random sampling selection process was performed to identify 600 eligible studies representative of the literature. Two reviewers independently extracted information on consideration of MCC in eligibility criteria and evaluated the reporting and consideration of MCC in trial analyses. Risk of bias was assessed using the Cochrane Collaboration Risk of Bias Tool. Results: In 600 behavioral intervention RCTs, targeting MCC was rare (4.3%). Exclusion of MCC was common (68.3%) and was done through general, specific, or vague exclusion criteria. 218 (36.3%) trials reported presence of MCCs through general or conditionspecific measures. Comorbidities were only considered in 4.8% of all trial analyses. Conclusions: In this comprehensive systematic review of 600 studies published from 2000-2014, RCTs testing behavioral interventions rarely consider individuals with MCC, limiting generalizability. Given the public health relevance and limited evidence base, this work highlights the urgent need to improve the consideration of MCC in clinical trial research.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N